You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 157 No. 9, 12 MAY 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Screening for Colorectal Cancer

A Comparison of 3 Fecal Occult Blood Tests

Bernard Levin, MD; Kenneth Hess, PhD; Constance Johnson

Arch Intern Med. 1997;157(9):970-976.


Abstract

Background
Colorectal cancer is the second leading cause of cancer deaths in the United States. Fecal occult blood testing has become a standard screening test for large-bowel cancers in the average asymptomatic population. Performance characteristics of the test and physician and participant compliance are the 2 major elements that impact the success of screening and early detection.

Objectives
To evaluate the nonhydrated Hemoccult, rehydrated Hemoccult, and Hemoccult SENSA tests (SmithKline Diagnostics Inc, Palo Alto, Calif) and to assess participant and physician compliance.

Methods
A mass community-based screening study in an urban setting. Kits were distributed by a local pharmacy and at community sites. Diagnostic tests were completed through physicians' offices and clinics. Participants were asymptomatic and aged 50 years or older. Those who tested positive were advised to follow up with a physician.

Results
An overall positivity rate of 16% was reported for the 8293 kits that were processed. Rehydrated Hemoccult had a positivity rate of 15%; Hemoccult SENSA, 7%; and nonhydrated Hemoccult, 5%. The positive predictive value of nonhydrated Hemoccult was 14%; rehydrated Hemoccult, 7%; and Hemoccult SENSA, 11%. Of those who tested positive, 59% had a colonoscopy or flexible sigmoidoscopy and double-contrast barium enema examination on follow-up. Recommended follow-up was more frequent for those who consulted a gastroenterologist.

Conclusions
Rehydrated Hemoccult yielded a higher positivity rate and lower positive predictive value than either Hemoccult SENSA or nonhydrated Hemoccult. Hemoccult SENSA approached the positive predictive value of nonhydrated Hemoccult. Adequacy of follow-up of patients testing positive for fecal occult blood needs improvement.

Arch Intern Med. 1997;157:970-976



Author Affiliations

From the Division of Cancer Prevention (Dr Levin and Ms Johnson) and the Department of Biomathematics (Dr Hess), The University of Texas M. D. Anderson Cancer Center, Houston.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Patient and Physician Reminders to Promote Colorectal Cancer Screening: A Randomized Controlled Trial
Sequist et al.
Arch Intern Med 2009;169:364-371.
ABSTRACT | FULL TEXT  

Barriers to full colon evaluation for a positive fecal occult blood test.
Fisher et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:1232-1235.
ABSTRACT | FULL TEXT  

Cost-Effective Screening for the Metabolic Syndrome in Patients Treated With Second-Generation Antipsychotic Medications
Straker et al.
Am. J. Psychiatry 2005;162:1217-1221.
ABSTRACT | FULL TEXT  

Physician Recommendations for Follow-Up of Positive Fecal Occult Blood Tests
Yabroff et al.
Med Care Res Rev 2005;62:79-110.
ABSTRACT  

A National Survey of Primary Care Physicians' Methods for Screening for Fecal Occult Blood
Nadel et al.
ANN INTERN MED 2005;142:86-94.
ABSTRACT | FULL TEXT  

What Factors Are Associated with Diagnostic Follow-Up after Abnormal Mammograms? Findings from a U.S. National Survey
Yabroff et al.
Cancer Epidemiol. Biomarkers Prev. 2004;13:723-732.
ABSTRACT | FULL TEXT  

Is the Promise of Cancer-Screening Programs Being Compromised? Quality of Follow-Up Care after Abnormal Screening Results
Yabroff et al.
Med Care Res Rev 2003;60:294-331.
ABSTRACT  

Population Colorectal Cancer Screening with Fecal Occult Blood Test
Rennert et al.
Cancer Epidemiol. Biomarkers Prev. 2001;10:1165-1168.
ABSTRACT | FULL TEXT  

Double-Contrast Barium Enema for Colorectal Cancer Screening: A Review of the Issues and a Comparison with Other Screening Alternatives
Glick
Am. J. Roentgenol. 2000;174:1529-1537.
FULL TEXT  

Diagnostic Testing Following Fecal Occult Blood Screening in the Elderly
Lurie and Welch
JNCI J Natl Cancer Inst 1999;91:1641-1646.
ABSTRACT | FULL TEXT  

Occult Gastrointestinal Bleeding
Rockey
NEJM 1999;341:38-46.
FULL TEXT  

Interference of Plant Peroxidases with Guaiac-based Fecal Occult Blood Tests Is Avoidable
Sinatra et al.
Clin. Chem. 1999;45:123-126.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.